Objects
Jackson, Melissa A., Baker, Amanda L., Gould, Gillian S., Brown, Amanda L., Dunlop, Adrian J., McCarter, Kristen. Wiley-Blackwell; 2022. Smoking cessation interventions for pregnant women attending treatment for substance use disorders: A systematic review.
Jackson, Melissa A., Brown, Amanda L., Gould, Gillian S., Dunlop, Adrian J., Baker, Amanda L., Bonevski, Billie, Haber, Paul, Bonomo, Yvonne, Blandthorn, Julie, Attia, John, Perry, Natasha, Barker, Daniel. Frontiers Research Foundation; 2023. Tobacco treatment incorporating contingency management, nicotine replacement therapy, and behavioral counseling for pregnant women who use substances: a feasibility trial.
Jackson, Melissa A., Brown, Amanda L., Phung, Nghi, Allsop, Dave, Dunlop, Adrian J., Johnston, Jennifer, Clancy, Richard, McGregor, Iain, Bruno, Raimondo, Lintzeris, Nick, Montebello, Mark, Luksza, Jennifer, Bowman, Jenny. BioMed Central Ltd.; 2021. The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients.
Mersha, Amanual Getnet, Kennedy, Michelle, Eftekhari, Parivash, Lee, K. S. Kylie, Upton, Penney, Segan, Catherine, Jackson, Melissa A., Jennings, Kirsty, Gould, Gillian Sandra. BioMed Central (BMC); 2023. Using the Behaviour Change Wheel and modified Delphi method to identify behavioural change techniques for improving adherence to smoking cessation medications.
Jackson, Melissa A., Buykx, Penny, Brown, Amanda L., Baker, Amanda L., Dunlop, Adrian J., Gould, Gillian S.. BioMed Central (BMC); 2022. Using mixed methods to establish tobacco treatment acceptability from the perspective of clients and clinicians of antenatal substance use services.
Montebello, Mark, Jefferies, Meryem, Lintzeris, Nicholas, Agonist Replacement For Cannabis Dependence Study Group (ARC-D),, Mills, Llewellyn, Bruno, Raimondo, Copeland, Jan, McGregor, Iain, Rivas, Consuelo, Jackson, Melissa A., Silsbury, Catherine, Dunlop, Adrian. Elsevier; 2022. Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial.